|
|
Volumn 11, Issue 2, 2005, Pages 210-212
|
|
Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INFLIXIMAB;
MESALAZINE;
PREDNISONE;
TUBERCULOSTATIC AGENT;
GASTROINTESTINAL AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ASPIRATION BIOPSY;
BACTERIAL INFECTION;
CANCER STAGING;
CASE REPORT;
COLON RESECTION;
COLONOSCOPY;
COMPUTER ASSISTED TOMOGRAPHY;
CROHN DISEASE;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
FEMALE;
HOSPITAL DISCHARGE;
HUMAN;
INFECTION RISK;
LETTER;
LIVER GRANULOMA;
LUNG GRANULOMA;
METASTASIS;
MYCOSIS;
PRIORITY JOURNAL;
TUBERCULOSIS;
GRANULOMA;
LIVER DISEASE;
LUNG DISEASE;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
FEMALE;
GASTROINTESTINAL AGENTS;
GRANULOMA;
HUMANS;
LIVER DISEASES;
LUNG DISEASES;
TREATMENT OUTCOME;
|
|
EID: 18244404860
PISSN: 10780998
EISSN: None
Source Type: Journal
DOI: 10.1097/00054725-200502000-00020 Document Type: Letter |
|
Times cited : (16)
|
|
References (7)
|
